University of Iowa Pharmaceuticals
Pharmaceutical Manufacturing • 
Iowa Bioscience Innovation Facility (IBIF), 115 South Grand Avenue, United States • 201-500 Employees
Company overview
| Headquarters | Iowa Bioscience Innovation Facility (IBIF), 115 South Grand Avenue, G-20, Iowa City, Iowa 52242, US |
| Phone number | +13193359418 |
| Websites | |
| NAICS | 3254 |
| Keywords | Stability Studies, Lyophilization, Formulation Development, Analytical Testing Services, Analytical Method Development And Validation, Clinical Supply Manufacturing, Api Release Testing, Small Scale Commerical Manufacturing, Sterile Filling, Tablets And Capsules |
| Founded | 1974 |
| Employees | 201-500 |
Key Contacts at University of Iowa Pharmaceuticals
Hima Bindu Gottam
Director Of Pre-Formulation And Formulation Development
Ryan Moreno
Director Of Manufacturing Operations
Laura Felleman
Director Of Finance
Jeff Millard
Director Of Quality
Tanner Morrison
Interim Director Quality Assurance
Jill Lynch
Director Sterile Products
Robert From
Clinical Director
Nancy Fraga
Assistant Director Recreational Services
Shami Lucena Morse
Co-Owner
Ken Lloyd
Owner
University of Iowa Pharmaceuticals Email Formats
University of Iowa Pharmaceuticals uses 5 email formats. The most common is {first name}{last name} (e.g., johndoe@uiowa.edu), used 77.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@uiowa.edu | 77.8% |
{first initial}{last name} | jdoe@uiowa.edu | 5.6% |
{first initial}-{last name} | j-doe@uiowa.edu | 5.6% |
{first name} | john@uiowa.edu | 5.6% |
{last name} | doe@uiowa.edu | 3.7% |
About University of Iowa Pharmaceuticals
University of Iowa Pharmaceuticals (UI Pharmaceuticals) is the largest and most established university-affiliated, FDA-registered pharmaceutical manufacturing facility in the United States. With over 50 years of experience operating under cGMP standards, we specialize in formulation development, product manufacturing, and analytical testing for clients across the pharmaceutical and biotechnology industries. In the past five years, UI Pharmaceuticals has produced more than 1,100 product batches for over 100 sponsors—ranging from startups to global enterprises. Our portfolio includes collaborations with government agencies such as the National Cancer Institute, CDC, and NIH, reflecting our broad reach and trusted reputation. We offer comprehensive dosage form capabilities, including: • Sterile injectable solutions & lyophilized powders • Oral & topical liquids, emulsions, and suspensions • Film-coated/uncoated tablets & hard gelatin capsules We are fully compliant with 21 CFR Parts 11, 210, and 211, licensed by the DEA (Schedules I–V), and equipped to handle potent/cytotoxic compounds. Our facilities have supported EU product launches, successfully passing multiple Qualified Person (QP) audits.
University of Iowa Pharmaceuticals revenue & valuation
| Annual revenue | $18,400,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $58,900,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
University of Iowa Pharmaceuticals has 123 employees across 12 departments.
Departments
Number of employees
Funding Data
University of Iowa Pharmaceuticals has never raised funding before.
United Arab Emirates
Germany
Frequently asked questions
4.8
40,000 users
